Key result
Co-infusion of ANP and mannitol increased distal tubular sodium delivery and urinary sodium excretion in responding patients with decompensated cirrhosis.
Why the study?
Does increasing distal tubular sodium delivery with mannitol reverse atrial natriuretic peptide (ANP) resistance in cirrhotic patients with ascites?
Does increasing distal tubular sodium delivery with mannitol reverse atrial natriuretic peptide (ANP) resistance in cirrhotic patients with ascites?
Increasing distal tubular sodium delivery with mannitol can reverse renal resistance to atrial natriuretic peptide in a subset of patients with decompensated cirrhosis.
Answers are grounded in this paper and cite their sources.
No immediate change to ascites care; small mechanistic study leaves open distal sodium delivery in ANP resistance.
To test the hypothesis that diminished sodium delivery to the distal tubular site of atrial natriuretic peptide (ANP) action accounts for renal ANP resistance in cirrhosis, 12 cirrhotic patients with ascites were studied at baseline and during the infusion of ANP alone (0.15 micrograms/kg/min), mannitol alone (4 g/hr), and ANP plus mannitol for 3 hours each. Distal tubular sodium delivery, as assessed by lithium clearance, was increased during the infusion of mannitol (13.8 +/- 3.4 to 23.7 +/- 5.7 mL/min; P < .05) and during the ANP plus mannitol infusion (13.8 +/- 3.4 to 28.5 +/- 6.3 mL/min; P < .001) in 6 patients, subsequently termed "responders." Both responders and nonresponders were resistant to the natriuretic effect of ANP infused alone, and mannitol alone did not produce an increase in urinary sodium excretion. However, in responders, the mannitol-induced increase in distal tubular sodium delivery resulted in a fivefold increase in urinary sodium excretion during ANP infusion (29 +/- 6 to 154 +/- 40 mumol/min, P < .01). Urinary cyclic guanosine monophosphate (cGMP) excretion increased significantly and to a similar extent during ANP and ANP plus mannitol in all 12 patients, supporting the active biological responsiveness of renal ANP receptors. Unlike responders, nonresponders showed a significant decrease in arterial blood pressure and an increase in plasma renin activity during ANP plus mannitol, consistent with worsened arterial underfilling caused by ANP-induced vasodilation. Thus, the present results support the hypothesis that diminished distal tubular sodium delivery is a major factor contributing to ANP resistance in cirrhosis.
No takes yet. Share an insight, caveat, or question.
Abraham et al. (1995) studied Decompensated cirrhosis with ascites (n=12). ANP plus mannitol vs. Baseline, ANP alone, and mannitol alone was evaluated on Urinary sodium excretion in responders (p=<.01). Co-infusion of ANP and mannitol increased distal tubular sodium delivery and urinary sodium excretion in responding patients with decompensated cirrhosis.
Synapse has enriched 10 related papers. Consider them for comparative context: